| Development and validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: a useful pharmacogenetic tool for prediction of … H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, ... Hepatitis Monthly 12 (3), 190, 2012 | 53 | 2012 |
| Effectiveness of methadone maintenance treatment in prevention of hepatitis C virus transmission among injecting drug users SM Alavian, A Mirahmadizadeh, M Javanbakht, A Keshtkaran, A Heidari, ... Hepatitis monthly 13 (8), 2013 | 46 | 2013 |
| Distribution of IL28B genotypes in Iranian patients with chronic hepatitis C and healthy individuals H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, S Salimi, ... Hepatitis Monthly 12 (12), 2012 | 39 | 2012 |
| Associations between human TRIM22 gene expression and the response to combination therapy with Peg‐IFNα‐2a and ribavirin in Iranian patients with chronic hepatitis C F Sadeghi, F Bokharaei‐Salim, M Salehi‐Vaziri, SH Monavari, ... Journal of medical virology 86 (9), 1499-1506, 2014 | 29 | 2014 |
| The role of polymorphisms near the IL28B gene on response to peg-interferon and ribavirin in thalassemic patients with hepatitis C B Behnava, H Sharafi, M Keshvari, A Pouryasin, L Mehrnoush, S Salimi, ... Hepatitis Monthly 16 (1), 2016 | 24 | 2016 |
| Efficacy of prolonged treatment with pegylated interferon (Peg-IFN) and ribavirin in thalassemic patients with hepatitis C who relapsed after previous Peg-IFN-based therapy S Sandoughdaran, SM Alavian, H Sharafi, B Behnava, S Salimi, ... Hepatitis Monthly 15 (1), 2015 | 23 | 2015 |
| The prevalence of hepatitis C virus core amino acid 70 substitution and genotypes of polymorphisms near the IFNL3 gene in Iranian patients with chronic hepatitis C D Kadjbaf, M Keshvari, SM Alavian, A Pouryasin, B Behnava, S Salimi, ... Hepatitis monthly 16 (6), 2016 | 19 | 2016 |
| Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state? S Sali, H Sharafi, SH Alavian, SM Alavian, F Etesam, S Salimi, MA Merza, ... Diagnostic microbiology and infectious disease 82 (2), 114-119, 2015 | 15 | 2015 |
| Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance-A Meta-Analysis SH Aalaei-Andabili, B Behnava, S Salimi, H Sharafi, SM Alavian Hepatitis monthly 14 (3), 2014 | 15 | 2014 |
| Impact of the IL-10 promoter gene polymorphisms in the severity of chronic hepatitis B infection SG Baghi, SM Alavian, L Mehrnoush, S Salimi Hepatitis monthly 15 (7), 2015 | 13 | 2015 |
| Efficacy and tolerability of peginterferon alpha-2a and peginterferon alpha-2b in Iranian patients with chronic hepatitis C M Pouresmaeeli, SM Alavian, M Keshvari, S Salimi, L Mehrnoush Hepatitis Monthly 15 (9), 2015 | 12 | 2015 |
| Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study M Abbasinazari, SM Alavian, B Behnava, M Asgharinia, S Salimi, ... Journal of Clinical and Diagnostic Research: JCDR 8 (12), HC16, 2014 | 12 | 2014 |
| The seroprevalence of entrically transmitted viral hepatitis in HCV infected thalassemia and hemophilia patients in Iran PK Elizee, SM Alavian, SM Miri, B Behnava, SH Alavian, M Keshvari, ... Jundishapur Journal of Microbiology 6 (7), 6, 2013 | 11 | 2013 |
| Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study. SM Miri, H Sharafi, S Salimi, F Bokharaei-Salim, B Behnava, M Keshvari, ... Iranian Red Crescent Medical Journal 19 (5), 2017 | 9 | 2017 |
| Plasma zinc level in hepatitis C patients with or without Beta thalassemia major; is there any difference? M Abbasinazari, B Behnava, Y Panahi, AH Talasaz, S Salimi, M Keshvari, ... Hepatitis Monthly 13 (8), 2013 | 7 | 2013 |
| Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection H Farzi, NE Daryani, L Mehrnoush, S Salimi, SM Alavian Hepatitis Monthly 14 (5), 2014 | 6 | 2014 |
| Liver hemangioma might lead to overestimation of liver fibrosis by Fibroscan; a missed issue in two cases SH Aalaei-Andabili, L Mehrnoush, S Salimi, M Shafiei, SM Alavian Hepatitis Monthly 12 (6), 408, 2012 | 6 | 2012 |
| Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders H Sharafi, B Behnava, A Azizi-Saraji, A Namvar, A Anvar, S Salimi, ... Virology Journal 18, 1-10, 2021 | 4 | 2021 |
| The role of polymorphisms Near IFNL3 gene as predictors of residual HCV RNA in buffy coat after successful antiviral therapy SM Miri, H Sharafi, A Pouryasin, B Behnava, M Keshvari, S Salimi, ... Hepatitis Monthly 17 (4), 6, 2017 | 4 | 2017 |
| High response rate to pegylated interferon alpha and ribavirin combination therapy in hemophilic children with chronic hepatitis C; a case-control study L Mehrnoush, SM Alavian, H Sharafi, B Behnava, S Salimi, M Keshvari Pediatric Hematology and Oncology 32 (6), 399-405, 2015 | 4 | 2015 |
Seyed Moayed AlavianProfessor of Internal Medicine-Research Center,Middle East Liver Disease Center, tehran, IranVerifierad e-postadress på thc.ir
